Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Places Genetic Analyzer at Undisclosed Top-5 Pharma

NEW YORK (GenomeWeb News) — Illumina today said that an undisclosed top-5 US pharma company has bought a “multi-component genetic analysis system” and will use Illumina's Infinium assay and HumanHap650Y BeadChip to provide whole-genome genotyping in a project involving over 3,200 samples.
This configuration will enable the pharma to generate as many as 45 million genotypes per day and run gene-expression applications and automated sample and array processing, Illumina said.
Though the drug maker was undisclosed, a person close to the deal suggested it is likely either GlaxoSmithKline or Merck. Both companies have had recent relationships with San Diego-based Illumina, as reported by GenomeWeb News sister publication BioArray News.
Financial terms of the deal were not disclosed, though Illumina said this is a multi-million dollar deal. The company said it will issue details, including the name of the company, during its third-quarter conference call later today.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.